Research Western
Funding Opportunites - Research
Further details regarding this announcement can be found at:
http://www.cihr-irsc.gc.ca/e/34309.html
Sponsor/Award: CANADIAN INSTITUTES HEALTH RESEARCH - CATALYST GRANT - INT COEN INITIATIVE IN NEURODEGENERATION - 2011 SPRING COMP

Grant Amount: UP TO 24 MTHS
Deadline: Dean's: Contact your Faculty Research Office for deadline details.
Internal: Jun 02, 2011
Sponsor's: Jun 09, 2011

Subject Areas: Alzheimer Disease And Related Dementia, Neurodegenerative Diseases, Huntington's Disease, Parkinson's Disease, Multiple Sclerosis, Motor Neuron Disease, Prion Disease
Description:

The CIHR Catalyst Grant program provides seed money, on a short-term basis, to support health research activities which represent a first step towards the pursuit of more comprehensive funding opportunities.

The Canadian Institutes of Health Research (CIHR), the Deutsches Zentrum f?r Neurodegenerative Erkrankungen (DZNE, Germany) and the Medical Research Council (MRC, UK) launched a funding initiative to establish collaborative activity between national centres of excellence in research into neurodegenerative disorders. The aim of the initiative is to build productive links between research groups within recognised centres of excellence in neurodegeneration, in partner countries, in order to add value to investments and accelerate progress in understanding the mechanisms of disease as well as the identification of new therapeutic approaches. It is expected that teams will combine the research strengths across at least two partner countries to provide a true value-added collaborative effort that will advance our approach to neurodegeneration research. Projects will address issues which would not readily be funded through the standard grant mechanisms of the Centres of Excellence in Neurodegeneration (COEN) partners, and it is expected that in addition collaboration across CoEs, projects should also serve to provide a platform for future collaboration.

Application Details: Randomized Controlled Trials (RCTs) will not be considered through this program. For projects of a high risk nature, the potential for great scientific gain should offset the risk of failure. There should be minimal or no overlap with other funded work.Type of projects to be supported: Pilot projects which could form the basis of future collaborative and innovative research, Development of methodologies and technological platforms, Working groups to establish `best practice? guidelines and standardized SOPs in the areas of imaging and cognitive measures. Only joint trans-national research projects will be funded. Each proposal must involve researchers from at least two CoEs (or eligible institutions) from different countries. Applications with three or more participating countries are encouraged. Applications must be submitted by email as a PDF copy of the application form to: coen(at)headoffice.mrc.ac.uk. All applications must be accompanied by a letter of support from the Director of the lead CoE of the proposal. For applications where the lead CoE is a Canadian Eligible Institution, the proposal must be accompanied by a letter from the Head of the Research Office.
NOTE: Letters of Intent and Full Applications are to be processed through Research Development Services for institutional signatures, and are to be accompanied by a completed RDAF form (bearing applicant, Chair and Dean signatures). Requests for Institutional signatures should be received no less than 3 days prior to the posted Sponsor deadline.
Western Contacts: Pocock,Katy
Russelo,Theresa M

Sponsor Contacts:

160 Elgin Street, 9th Floor
Address Locator 4809A
OTTAWA, Ontario, Canada
613 941-2672